Article Information
History
- July 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthias Walter1,2,†,
- Andrea L. Ramirez1,
- Amanda H. X. Lee1,
- Thomas E. Nightingale1,3,4,
- Daniel Rapoport5,
- Alex Kavanagh5 and
- Andrei V. Krassioukov1,6,7,†
- 1International Collaboration on Repair Discoveries (ICORD), Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 2Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland
- 3School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK
- 4Centre for Trauma Sciences Research, University of Birmingham, Edgbaston, Birmingham, UK
- 5Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 6Division of Physical Medicine and Rehabilitation, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 7G.F. Strong Rehabilitation Centre, Vancouver, British Columbia, Canada
- ↵†Corresponding authors:
Matthias Walter MD, PhD, FEBU, Department of Urology, University Hospital Basel, University of Basel, Spitalstrasse 21, 4031 Basel, Switzerland, E-mail: dr.matze{at}gmx.de, Phone: +41 61 328 59 57, Andrei V. Krassioukov, MD, PhD, FRCPC, International Collaboration on Repair Discoveries (ICORD), Faculty of Medicine, University of British Columbia, 818 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1M9, E-mail: krassioukov{at}icord.org, Phone: 605 675 8819, Fax: 604 675 8820
Posted July 17, 2022.
Fesoterodine ameliorates autonomic dysreflexia while improving lower urinary tract function and urinary incontinence-related quality of life in individuals with spinal cord injury: A prospective phase IIa study
